750 Welch Road, Suite 200, Palo Alto, CA 94304, USA.
Clin J Am Soc Nephrol. 2010 Mar;5(3):497-502. doi: 10.2215/CJN.05280709. Epub 2010 Jan 28.
To ensure long-term safety of living kidney donors, it is now recommended that they be followed for at least 2 years after donation and that serum creatinine levels be monitored. Such levels are often subjected by clinical laboratories to estimating equations and are reported as estimated GFR (eGFR). The accuracy of such equations in uninephric living donors has yet to be validated. This is especially important in older living donors, who often have senescence-related depression of GFR.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We compared urinary creatinine clearance, four-variable Modification of Diet in Renal Disease estimating equation (eGFR), and the recently reported CKD-EPI GFR estimating equation with true GFR measured by the urinary iothalamate clearance (iGFR) in 64 subjects after kidney donation.
Creatinine clearance overestimated iGFR. Both creatinine-based estimating equations were poorly correlated with and underestimated iGFR. More than half of kidney donors had eGFR <60 ml/min per 1.73 m(2) after donation, a level that categorized them as having stage 3 chronic kidney disease by our current laboratory reporting, whereas only 25% had iGFR <60 ml/min per 1.73 m(2). This misclassification disproportionately affected older donors age > or =55 years, of whom 80% had eGFR <60 ml/min per 1.73 m(2). Neither significant albuminuria nor hypertension was observed.
The current practice of reporting eGFR after donation commonly leads to a misclassification of chronic kidney disease, particularly in older donors. To ensure long-term well-being of living kidney donors, more precise estimates of GFR are required, particularly among older potential donors.
为确保活体肾捐献者的长期安全,目前建议在捐献后至少随访 2 年,并监测血清肌酐水平。临床实验室通常会对这些水平进行估算方程处理,并将其报告为估算肾小球滤过率(eGFR)。这些方程在单肾捐献者中的准确性尚未得到验证。这在老年活体供者中尤为重要,因为他们的 GFR 往往因衰老相关而降低。
设计、地点、参与者和测量方法:我们比较了 64 例肾移植后的尿肌酐清除率、四变量改良肾脏病饮食方程(eGFR)和最近报道的 CKD-EPI GFR 估算方程与通过尿碘酞酸盐清除率(iGFR)测量的真实 GFR。
肌酐清除率高估了 iGFR。两种基于肌酐的估算方程与 iGFR 的相关性均较差且低估了 iGFR。超过一半的肾移植供者在捐献后 eGFR<60ml/min/1.73m2,按照我们当前的实验室报告标准,他们被归类为患有 3 期慢性肾脏病,而仅有 25%的供者 iGFR<60ml/min/1.73m2。这种错误分类不成比例地影响了年龄≥55 岁的老年供者,其中 80%的 eGFR<60ml/min/1.73m2。未观察到明显的白蛋白尿或高血压。
目前在捐献后报告 eGFR 的做法通常会导致慢性肾脏病的错误分类,尤其是在老年供者中。为确保活体肾捐献者的长期健康,需要更精确的 GFR 估计值,尤其是在老年潜在供者中。